Aurizon (3 mg + 10 mg + 1 mg)/ml Krople do uszu, zawiesina
Aurizon (3 mg + 10 mg + 1 mg)/ml Krople do uszu, zawiesina
Authorised
- Dexamethasone acetate
- Clotrimazole
- Marbofloxacin
Product identification
Medicine name:
Aurizon (3 mg + 10 mg + 1 mg)/ml Krople do uszu, zawiesina
Active substance:
- Dexamethasone acetate
- Clotrimazole
- Marbofloxacin
Target species:
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Dexamethasone acetate1.00/milligram(s)1.00millilitre(s)
-
Clotrimazole10.00/milligram(s)1.00millilitre(s)
-
Marbofloxacin3.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Withdrawal period by route of administration:
-
Auricular use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- VETOQUINOL SA
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- URPL
Authorisation number:
- 1455
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
